bpc-157 quadriceps tendon healing A-H. Gross presentation of injury severity. A poor course in all Orthopedic Use of BPC-157 -

This could give it broader therapeutic potential for: As of 2025, Dihexa has not yet entered large-scale, double-blind, placebo-controlled clinical trials for widespread human use

Additional information Informed consent The authors affirm that patient participants provided informed consent for publication of their experiences

Treating a deficiency can help remove these barriers

Perform Better with B12 The most reliable performance signal from B12 supplementation appears when correcting an existing deficiency rather than supplementing on top of adequate baseline

Fortinos patients typically receive B12 injections together with MIC lipotropic injections weekly at his Philadelphia and New Jersey diet clinics